To include your compound in the COVID-19 Resource Center, submit it here.

Analyst picks & changes

Analyst picks & changes

Company Bank Analyst Coverage Opinion Wk chg 7/8 close
Cepheid Inc. (NASDAQ:CPHD) Goldman Sachs Isaac Ro Downgrade Neutral (from buy) -8% $32.40
Ro downgraded based on Cepheid's strong stock performance. He noted the molecular diagnostic company's stock has risen 40% since he initiated

Read the full 613 word article

Trial Subscription

Get a two-week free trial subscription to BioCentury

SIGN UP

Article Purchase

This article may not be distributed to non-subscribers
More Info >PURCHASE